Progression from F3 to cirrhosis occurred in roughly one year, contrasting STELLAR’s 13% over four years and suggesting trials may underrepresent real-world risk. Among compensated cirrhosis, 29.7% ...

Use our in-depth glossary to find out if you're a based chad who has aura or a delulu chud in danger of being mogged.

Starting July 1, Medicare will cover three Ozempic-style weight-loss medications for $50 per month through a new temporary ...

Sokujo sake brewing is the modern starter method using added lactic acid. Learn how it works, its history, and flavor.

The global affiliate marketing industry has crossed a critical threshold, reaching approximately $17 billion in 2025 and ...

The global gaming industry, a powerhouse of entertainment and economic activity, finds itself at a pivotal juncture, grappling with significant internal ...

The Supreme Court began hearing cases for the term on October 7, 2024. The court's yearly term begins on the first Monday in October and lasts until the first Monday in October the following year. The ...

In SYNCHRONIZE-MASLD (n=218), 84.2% on weekly survodutide 6.0 mg achieved ≥30% relative liver fat reduction versus 24.3% with placebo at week 48. Liver fat normalization occurred in ~61% of ...

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

Long-term investors who can patiently wait to buy may want to do so, as the expectations built into this stock could easily ...